AQR Capital Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-54,104
| Closed | -$4.6M | – | 2241 |
|
|
2019
Q4 | $4.6M | Buy |
+54,104
| New | +$3.61M | 0.01% | 988 |
|
|
2017
Q3 | – | Sell |
-14,772
| Closed | -$561K | – | 2322 |
|
|
2017
Q2 | $561K | Buy |
14,772
+6,817
| +86% | +$304K | ﹤0.01% | 1852 |
|
|
2017
Q1 | $389K | Buy |
+7,955
| New | +$363K | ﹤0.01% | 1955 |
|
|
2016
Q4 | – | Sell |
-15,546
| Closed | -$587K | – | 2310 |
|
|
2016
Q3 | $587K | Sell |
15,546
-9,322
| -37% | -$351K | ﹤0.01% | 1893 |
|
|
2016
Q2 | $836K | Sell |
24,868
-1,631
| -6% | -$57.5K | ﹤0.01% | 1678 |
|
|
2016
Q1 | $842K | Buy |
26,499
+303
| +1% | +$9.9K | ﹤0.01% | 1645 |
|
|
2015
Q4 | $978K | Buy |
26,196
+16,211
| +162% | +$613K | ﹤0.01% | 1583 |
|
|
2015
Q3 | $379K | Buy |
+9,985
| New | +$350K | ﹤0.01% | 1832 |
|
|
2014
Q4 | – | Sell |
-16,235
| Closed | -$362K | – | 2680 |
|
|
2014
Q3 | $362K | Buy |
16,235
+100
| +0.6% | +$2.54K | ﹤0.01% | 2085 |
|
|
2014
Q2 | $469K | Sell |
16,135
-4,900
| -23% | -$131K | ﹤0.01% | 2018 |
|
|
2014
Q1 | $598K | Sell |
21,035
-10,472
| -33% | -$347K | ﹤0.01% | 1952 |
|
|
2013
Q4 | $1.22M | Buy |
31,507
+13,400
| +74% | +$479K | ﹤0.01% | 1630 |
|
|
2013
Q3 | $607K | Sell |
18,107
-54,600
| -75% | -$1.74M | ﹤0.01% | 1894 |
|
|
2013
Q2 | $2.24M | Buy |
+72,707
| New | +$2.43M | 0.01% | 1214 |
|
Other funds holding MDCO
AQR Capital Management's MDCO Position: Q1 2020 in Review
AQR Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 54,104 shares — an estimated $4.6M sold.
AQR Capital Management first reported a position in MDCO in Q2 2013 and held it in 14 quarters. The position peaked at $4.6M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- AQR Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- AQR Capital Management sold 54,104 Medicines Co shares in Q1 2020, an estimated $4.6M.
- AQR Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 14 quarters.
- AQR Capital Management's Medicines Co position peaked at $4.6M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on AQR Capital Management's 13F filing for Q1 2020, filed 15 May 2020.